Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma [Phase 2]
Phase 2 trial evaluating the combination of nivolumab, ipilimumab, and cabozantinib in patients with unresectable advanced melanoma; results…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Radiotherapy & Combi in Metastatic Melanoma [Phase 1, Phase 2]
The study evaluating radiotherapy in combination with other therapies for metastatic melanoma has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Neurotropic Melanoma of the Head and Neck [NA]
A clinical trial update notes completion of a study on neurotropic melanoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma [NA]
This clinical trial update reports the completion of NCT04920162, a study investigating new predictive markers of the immune response in mel…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Skin Health Online for Melanoma: Better Risk Assessment [NA]
A completed clinical trial evaluating Skin Health Online for Melanoma to improve risk assessment; results are posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Pegilodecakin (LY3500518) in patients with advanced solid tumors has completed, spanning multiple indications including mel…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection
The compassionate use program for BRAF mutation-positive melanoma patients after surgical resection is no longer available.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Imaging FDG Flare in Melanoma
The update summarizes results from a completed study investigating FDG PET imaging flare in metastatic melanoma, with results posted in 2024…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery [NA]
A clinical trial evaluating nicotine replacement therapy, motivational interviewing, cognitive behavioral therapy, and hypnotherapy for smok…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination [Phase 1]
Pfizer's Phase 1 study of PF-07329640, given alone or in combination, in advanced/metastatic solid tumors including non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) [Phase 1]
HAMMER I is a Phase I trial evaluating hepatic ablation of melanoma liver metastases to enhance response to immunotherapy; the study status …
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours [Phase 1]
This clinical trial update reports the completion of a first-in-human Phase 1 study evaluating AZD8701 with or without durvalumab in adults …
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]
A Phase 1 study evaluating MT-8421 as monotherapy and in combination with nivolumab in selected advanced solid tumors has been terminated. T…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy [Phase 2]
Phase 2 trial update on managing pyrexia with an IL-6 antibody in BRAF-positive melanoma patients treated with dabrafenib/trametinib; the tr…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 trial update evaluating SB 11285 alone and in combination with atezolizumab in patients with advanced solid tumors, includ…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma [Phase 1]
Phase 1 trial evaluating a personalized neoantigen vaccine in combination with locally administered ipilimumab and systemic nivolumab for ad…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Fecal Microbiota Transplant (FMT) in Melanoma Patients [Phase 2]
A Phase 2 trial evaluating fecal microbiota transplant in melanoma has completed, with results posted on 2024-10-30.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma [Phase 2]
Phase 2 trial evaluating dabrafenib, trametinib, and spartalizumab in BRAF V600E/V600K mutation-positive stage IIIB/IIIC/IIID cutaneous mela…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma [Phase 1]
Pfizer's Phase I trial of the oral BRAF inhibitor LGX818 in adults with BRAF-mutant melanoma has completed and posted results. The study als…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer [Phase 1]
This Phase 1 trial update reports termination of the INBRX-105 in combination with pembrolizumab across multiple solid tumors, including hea…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination with Nivolumab Vs. Nivolumab [Phase 2]
Phase 2 study evaluating Vidutolimod (CMP-001) in combination with Nivolumab versus Nivolumab alone in melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Milademetan in Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 trial of milademetan in advanced or metastatic solid tumors was terminated, with results posted in October 2024.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
This Phase 1 trial assessed the combination of onalespib with dabrafenib and trametinib in patients with BRAF-mutant melanoma or metastatic/…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: AI Augmented Training for Skin Specialists [NA]
A completed clinical trial sponsored by Herlev Hospital evaluating AI-augmented training for skin specialists in diagnosing melanoma and oth…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients [NA]
A completed clinical trial investigated how acute and chronic exercise affects myeloid-derived suppressor cells in patients with melanoma.